About Nicox SA.

Company Description

Developing innovative ocular solutions

Nicox is an international ophthalmology company developing innovative therapeutics to help maintain vision and improve ocular health.

We plan to keep the maximum of options open for the company by maintaining rights to our novel therapeutics for eye diseases in key territories, such as the U.S. and Europe, as we create value by advancing their development, maintaining the potential for direct marketing, licensing for certain territories and growth through strategic transactions.

We are focused on the discovery, development and commercialization of novel ophthalmic therapeutics for eye diseases.

Year founded

1996

Served area

Worldwide

Headcount

32

Headquarters

Drakkar 2 - Bâtiment D 2405 Route des Dolines, 6560 Valbonne – France

Shareholder information

Shares outstanding

43,223,135

IPO

Dec. 29, 2000

Stock exchange(s)

Euronext Paris

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.